News
Public · Published
JYOTHYLAB: Revenue rose, profit fell sharply, and a ₹147 crore share buyback was approved
Jyothy Labs reported that Q2 FY27 revenue increased year over year, while net profit fell to ₹1,060 lakh from ₹8,776 lakh. Its Board approved a ₹147 crore share buyback through a tender offer at ₹215 per share, and promoters intend not to participate.
Published:
Updated:
What happened
Jyothy Labs reported that Q2 FY27 revenue increased year over year, while net profit fell to ₹1,060 lakh from ₹8,776 lakh. Its Board approved a ₹147 crore share buyback through a tender offer at ₹215 per share, and promoters intend not to participate.
Confirmed
Global impact / market context
The sharp profit decline despite higher revenue suggests costs or other factors reduced earnings, though the supplied report gives no cause. The buyback would use company cash to repurchase shares, while promoter non-participation may affect how many shares other shareholders can tender.
Analyst inference
Investors must weigh the earnings decline against the proposed return of cash through the buyback. The ₹215 tender price is a stated offer price, not evidence of a market-price change; the report provides no details on the buyback’s timing or completion.
Analyst inference
What to watch
- Watch for the company’s fuller results and any explanation of why net profit fell while revenue increased; the supplied summary does not identify the cause. Analyst inference
- Check the tender-offer timetable and final terms, including how many shares the company will repurchase and whether the Board’s approval proceeds to completion. Analyst inference
- Track how many shares promoters tender, if any, since they intend not to participate; that could influence the number available for other shareholders to sell. Analyst inference
Evidence
- Original source link unavailable